Outcome of the Board Meeting held on October 22, 2026

Ref: PFL/ BSE/2026-27/97 Date: October 22, 2026 BSE Limited The Corporate Relationship Department P.J. Towers, 1st Floor, Dalal Street, Mumbai – 400001 Equity Debt Scrip 544191 977452 977715 977718 977748 978011 978238 Code Scrip PURPLEFIN 1225PFL28 1250PFL31 PFL06426 12PFL28 1190PFL28 1190PFL29 Sub: Intimation under Regulation 30 and Regulation 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Outcome of the Board Meeting held on October 22, 2026 Dear Sir/Madam, Pursuant to Regulation 30, Regulation 33, Regulation 51 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we wish to inform you that the Board of Directors of the Company, at its meeting held on Thursday, October 22, 2026, have inter-alia approved the following: 1. The Unaudited Standalone and Consolidated Financial Results along with Limited Review Report issued by Jogin Raval & Associates, Chartered Accountants for the quarter and half year ended September 30, 2026 which have been duly reviewed and recommended by the Audit Committee along with the Security Cover Certificate for the quarter ended September 30, 2026. 2. Shifting of Registered Office from ‘Room No. 11, 1st Floor, Indu Chamber 349/353, Samuel Street, Vadgadi, Masjid Bunder (West), Mumbai, Maharashtra, India, 400003’ to ‘5/502, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Gurunanak Hospital Bandra East, Mumbai- 400051’ with effect from October 23, 2026. Purple Finance Limited Registered Office: 11, Indu Chamber, 349/353, Samuel Street, Masjid Bunder West, Mumbai – 400003. Corporate Office: 5/502, 5th Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Guru Nanak Hospital, Bandra (E), Mumbai- 400051 Tel. No.: +91-22 6916 5100 | www.purplefinance.in | CIN No. L67120MH1993PLC075037 | customersupport@purplefinance.in 3. Launch of new financing products: i. The Company has approved the launch of two MSME-focused lending products, namely “PURPLE SARAL” and “SAKSHAM LAP”, which, alongside the Company’s existing lending activities under PURPLE, will enable the Company to cater to the full spectrum of the MSME sector. ii. The Company has also introduced a new institutional lending product aimed at providing financing solutions to Non-Banking Financial Companies (NBFCs) in the MSME sector. The disclosure as required under Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 January 30, 2026, is attached as Annexure I, Annexure II and Annexure III. The Board Meeting commenced at 03:58 p.m. and concluded at 06:04 p.m. The aforementioned information will be available at the website of the Company at www.purplefinance.in This is for your information and records. Thanking You, Yours faithfully, For Purple Finance Limited Ruchi Nishar Company Secretary and Compliance Officer Encl: A/a Purple Finance Limited Registered Office: 11, Indu Chamber, 349/353, Samuel Street, Masjid Bunder West, Mumbai – 400003. Corporate Office: 5/502, 5th Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Guru Nanak Hospital, Bandra (E), Mumbai- 400051 Tel. No.: +91-22 6916 5100 | www.purplefinance.in | CIN No. L67120MH1993PLC075037 | customersupport@purplefinance.in Annexure I Minimum Information to be disclosed to the Stock Exchange as per Master Circular dated January 30, 2026, for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities. Sr. No. Particulars Details 1. Name of the Product Saral 2. Date of launch November 01, 2026 3. Category of the product Unsecured Lending 4. Whether caters to domestic/ international Domestic Market market; 5. Name of the countries in which the product is Not Applicable launched (in case of international) Purple Finance Limited Registered Office: 11, Indu Chamber, 349/353, Samuel Street, Masjid Bunder West, Mumbai – 400003. Corporate Office: 5/502, 5th Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Guru Nanak Hospital, Bandra (E), Mumbai- 400051 Tel. No.: +91-22 6916 5100 | www.purplefinance.in | CIN No. L67120MH1993PLC075037 | customersupport@purplefinance.in Annexure – II Sr. No. Particulars Details 1. Name of the Product Saksham - LAP 2. Date of launch October 28, 2026 3. Category of the product Secured Lending 4. Whether caters to domestic/ international Domestic Market market; 5. Name of the countries in which the product is Not Applicable launched (in case of international) Purple Finance Limited Registered Office: 11, Indu Chamber, 349/353, Samuel Street, Masjid Bunder West, Mumbai – 400003. Corporate Office: 5/502, 5th Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Guru Nanak Hospital, Bandra (E), Mumbai- 400051 Tel. No.: +91-22 6916 5100 | www.purplefinance.in | CIN No. L67120MH1993PLC075037 | customersupport@purplefinance.in Annexure – III Sr. No. Particulars Details 1. Name of the Product Loan to NBFC 2. Date of launch October 28, 2026 3. Category of the product Secured Lending 4. Whether caters to domestic/ international Domestic Market market; 5. Name of the countries in which the product is Not Applicable launched (in case of international) Purple Finance Limited Registered Office: 11, Indu Chamber, 349/353, Samuel Street, Masjid Bunder West, Mumbai – 400003. Corporate Office: 5/502, 5th Floor, Hallmark Business Plaza, Sant Dnyaneshwar Marg, Opp. Guru Nanak Hospital, Bandra (E), Mumbai- 400051 Tel. No.: +91-22 6916 5100 | www.purplefinance.in | CIN No. L67120MH1993PLC075037 | customersupport@purplefinance.in Independent Auditor’s Limited Review Report on Standalone Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) The Board of Directors Purple Finance Limited Mumbai 1. We have reviewed the accompanying statement of unaudited financial results of Purple Finance Limited (‘the Company’) for the quarter ended September 30, 2026 and year to date from April 01, 2026 to September 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Company’s Management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’ (‘Ind AS 34’), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder and in compliance with the Regulations and directions issued by the Reserve Bank of India (“the RBI”) from time to time, applicable to NBFC (“the RBI guidelines”), the listing regulations and other recognized accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identi [Showing first 8,000 characters — download PDF for full document]